Immunosuppressant medication in cardiac transplant patients - between therapeutic benefit and iatrogenic pathology
Open Access
|Mar 2013References
- 1. Oellerich M., Amstrong VW. & Kahan B. et al. (1995) Lake Louise consensus conference on cyclosporin monitoring in organ transplantation: report of consensus panel,17, 642-654
- 2. Kahan BD., Shaw LM. & Hold D. et al. (1990) Consensus document: Haw’s Cay meting on therapeutic drug monitoring of cyclosporine,36, 1510-6
- 3. Levey AS., Coresh J., Greene T., Stevens LA., Zhang YL. & Hendriksen S., et al. (2006). Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the Modification of Diet in Renal Disease study equation for estimating glomerular filtration rate.145(4), 247-254.
- 4. Miller WG. (2011). Glomerular Filtration Rate. The Importance of Standardized Serum Creatinine in Detecting Kidney Disease.37(12), 10-12.
- 5. Marqut P., Leger F., Pisano P. & Billaud EM. (2004)., (pp 280-293). Paris: Elsevier
- 6. Tedesco D. & Haragsim L. (2012). Cyclosporine: A Review,, Article ID 230386, 7 pages. DOI:10.1155/2012/230386
- 7. Martins L., Ventura A. & Branco A. et al. (2004). Cyclosporine versus tacrolimus in kidney transplantation: are there differences in nephrotoxicity?36(4), 877-879.
- 8. Ojo AO., Held P.J. & Port F.K. et al. (2003). Chronic renal failure after transplantation of a nonrenal organ.. 349(10), 931-940
- 9. Ispas M., Chincisan C., Voidăzan S., Mărginean A. & Dobreanu M. (2012). Chronic kidney disease after treatment with cyclosporine or tacrolimus in heart transplant recipients - experience of a Romanian medical center.20(2/4), 117-125
- 10. Castel M.A., Farrero M., Vallejos I., Cardona M., Regueiro A. & Pérez-Villa F. (2011). Primary immunosuppression and outcome differences after heart transplantation: tacrolimus versus cyclosporine.. 43(6), 2244-6
- 11. Meiser B.M., Groetzner J. & Kaczmarek I. et al (2004). Tacrolimus or cyclosporine: which is the better partner for mycophenolate mofetil in heart transplant recipients?. 78(4), 591-8.
- 12 Baran D.A., Zucker M.J. & Arroyo L.H. et al. (2011). A prospective, randomized trial of singledrug versus dual-drug immunosuppression in heart transplantation: the tacrolimus in combination, tacrolimus alone compared (TICTAC) trial.. 4(2), 129-37
- 13. Kobashigawa J.A. (2011). Strategies in immunosuppression after heart transplantation: is less better?. 4(2), 111-3
- 14. Garlicki M. (2005). Post-transplant diabetes mellitus (PTDM) in heart recipients,10(3), 51-3
- 15. Simmonds J., Dewar C., Dawkins H., Burch M. & Fenton M. (2009). Tacrolimus in pediatric heart transplantation: ameliorated side effects in the steroid-free, statin era.. 23(3), 415-419
- 16. Morales J.M., Andrés A. & Dominguez-Gil B. et al. (2005). Ten years of treatment with tacrolimus is related to an excellent renal function, allowing monotherapy in a large proportion of cases: unicentric results of the tacrolimus versus cyclosporine. A European multicentric study in kidney.. 37(9), 3738-3742
Language: English
Page range: 101 - 111
Published on: Mar 13, 2013
Published by: Ovidius University of Constanta
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2013 C.E. Vari, H. Suciu, Mihaela Ispas, S. Voidăzan, Daniela Lucia Muntean, published by Ovidius University of Constanta
This work is licensed under the Creative Commons License.